About US
Contact us
-
AstraZeneca and Isis Pharmaceuticals partner for target oligonucleotides delivery methodsBritish-Swedish drugmaker AstraZeneca has partnered with US-based Isis Pharmaceuticals to develop new delivery methods for antisense oligonucleotides. According to Isis, new methods are being develop2014/11/18
-
GSK launches first call for proposals for NCDs research in AfricaGlaxoSmithKline (GSK) has launched the first call for proposals for its Africa NCD Open Lab to support scientific research into non-communicable diseases (NCDs) in Africa. In sub-Saharan Africa and a2014/11/17
-
GSK seeks European approval for eltrombopag to treat severe aplastic anaemiaBritish drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). The ap2014/11/14
-
Eurofins Genomics Is First Genomics Service Provider in Germany to Achieve GLP CertificationEurofins Genomics is the first genomics service provider in Germany to achieve good laboratory practice (GLP) certification for DNA sequencing services. GLP is a required standard for laboratories co2014/11/13
-
FDA approves Amgen’s BLA for high cholesterol treatment evolocumabAmgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The FDA accepted Biologics License Application (BLA) for evolocumab, an2014/11/13
-
Takeda and GE Healthcare partner to develop therapeutic drugs for liver diseasesJapan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development of hepatic fibrosis. Hepatic fibrosis is an important factor in the diagnosis and tr2014/11/13
-
7PSolutions Announces New Additions in Brazil and ChinaIn an ongoing effort to provide clients with uninterrupted visibility to global supply chains, 7PSolutions are proud to announce new additions to their global service offerings, in Brazil and China.2014/11/12
-
SMC approves BMS’ Daklinza and Yervoy to treat patients within NHS ScotlandThe Scottish Medicines Consortium (SMC) has approved Bristol-Myers Squibb's (BMS) Daklinza (daclatasvir) for use within NHS Scotland to treat adult patients with chronic hepatitis C. Daclatasvir rece2014/11/12
-
FDA approves Amgen’s BLA for high cholesterol treatment evolocumabAmgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The FDA accepted Biologics License Application (BLA) for evolocumab, an2014/11/12
-
Perrigo to buy OTC drug-maker Omega Pharma for $4.5bnIreland-based Perrigo has signed an agreement to acquire Belgium's over-the-counter (OTC) drug-maker Omega Pharma, for €3.6bn ($4.5bn). The transaction includes the purchase of Omega's equity for €2.2014/11/11